Vertex Pharmaceuticals (VRTX)
$183.53 7.30 (4.14%)
19:59 EDT VRTX Stock Quote Delayed 15 Minutes
Previous Close $183.53
Market Cap 46.77B
PE Ratio 213.41
Volume (Avg. Vol.) 1.29M
Day's Range 174.82 - 184.81
52-Week Range 151.80 - 195.81
Dividend & Yield N/A (N/A)
VRTX Stock Predictions, Articles, and Vertex Pharmaceuticals News
- From InvestorPlace
- From the Web
Investors looking for the safety of large-cap stocks alongside impressive growth should consider these five investments.
The stock charts of CAG, VRTX and HFC are poised to end the trading week in pivotal situations. Here's what you should know about each.
Here we take a closer look at five stocks with bullish calls from Goldman Sachs. As you will see, each of these stocks shows over 20% upside potential from current levels.
The stock charts of FTI, VRTX and STZ are knocking on the doors of major moves, even if the broad market isn't.
The long term is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.
The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.
Even in these unstable times, there are still gems to be found. And these are 10 of the hottest stocks on the Street, complete with "strong buy" analyst ratings and some compelling growth drivers.
Stock charts of VRTX, NKTR and SYMC are going to end the trading week knocking on the door of major moves.
Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?
One of the best mutual funds last year was the T. Rowe Price Health Sciences Fund. Here are 7 healthcare stocks to buy from its holdings.
Put these fast-growing stocks on your radar, if not in your portfolio, as your best shot at overcoming the market's summertime blues.
The market volatility isn't all bad! Now investors can find stocks to buy at killer entry points --determined by the Street's stop analysts.
Morgan Stanley says these stocks are set to outperform even if the market slows down in 2019. That makes these 10 excellent stocks to buy for careful investors.
These four stocks are among the best U.S. stocks to buy today, as they beat S&P 500 growth rates in the past and should maintain strong growth rates in the years ahead.
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!